Sheau-Chiann Chen Selected Research

congenital Melanocytic nevus syndrome

11/2015	Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.
8/2015	Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheau-Chiann Chen Research Topics

Disease

26	Neoplasms (Cancer) 02/2024 - 01/2016
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
7	Melanoma (Melanoma, Malignant) 07/2023 - 06/2016
5	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2021
4	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2017
3	Pathologic Constriction (Stenosis) 09/2023 - 12/2021
2	Lipedema 10/2023 - 01/2022
2	Pain (Aches) 10/2023 - 01/2022
2	Thyroid Neoplasms (Thyroid Cancer) 10/2023 - 10/2023
2	Inflammation (Inflammations) 09/2023 - 01/2022
2	Disease Progression 09/2023 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2018
2	Rheumatoid Arthritis 01/2022 - 06/2021
2	Retinal Degeneration 11/2021 - 01/2021
2	Triple Negative Breast Neoplasms 01/2020 - 08/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2016
2	Neutropenia 01/2019 - 08/2017
2	congenital Melanocytic nevus syndrome 11/2015 - 08/2015
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Insulin Resistance 01/2022
1	Lymphedema (Milroy Disease) 01/2022
1	Cytopenia 01/2021
1	Toxic Optic Neuropathy 01/2021
1	Cytokine Release Syndrome 10/2020
1	COVID-19 10/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Infections 01/2020

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2017
6	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2019
5	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2020
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 08/2015
4	Retinaldehyde (Retinal)IBA 01/2022 - 01/2021
3	Estrogen ReceptorsIBA 01/2022 - 01/2017
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 10/2023 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2017
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2022 - 01/2019
2	Cyclin D1IBA 01/2022 - 01/2019
2	ChemokinesIBA 06/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 08/2017
2	Chemokine ReceptorsIBA 01/2021 - 10/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019
1	EnzymesIBA 09/2023
1	Estrogens (Estrogen)FDA Link 09/2023
1	ON 01910IBA 07/2023
1	SteroidsIBA 01/2023
1	ruxolitinibIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	GenieIBA 01/2022
1	AcetaldehydeIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	SodiumIBA 01/2022
1	Notch1 ReceptorIBA 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2021
1	Proton Pump InhibitorsIBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	belinostatIBA 11/2021
1	CalciumIBA 06/2021
1	MicroRNAs (MicroRNA)IBA 06/2021
1	AlpelisibIBA 05/2021
1	gedatolisibIBA 05/2021
1	copanlisibIBA 05/2021
1	dabrafenibIBA 01/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	trametinibIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	15-keto-13,14-dihydroprostaglandin F2alpha (PGFM)IBA 01/2021
1	SolutionsIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020
1	tocilizumab (atlizumab)FDA Link 10/2020
1	2-(aminomethyl)phenolIBA 01/2020
1	PhosphoproteinsIBA 01/2020
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2020
1	enzalutamideIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020

Therapy/Procedure

14	Therapeutics 10/2023 - 06/2016
5	Immunotherapy 10/2023 - 06/2016
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2021
2	Injections 01/2023 - 01/2021
2	Precision Medicine 01/2017 - 01/2016
1	Thyroidectomy 10/2023
1	Conservative Treatment 01/2022
1	Musculoskeletal Manipulations (Manipulative Therapy) 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Anesthesia 01/2021
1	Intravitreal Injections 01/2021